Iridium-192 versus cobalt-60 boost in 3–7 cm breast cancer treated by irradiation alone: final results of a randomized trial
- 1 February 1995
- journal article
- clinical trial
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 34 (2) , 114-120
- https://doi.org/10.1016/0167-8140(94)01492-l
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Randomized Clinical Trial to Assess the Effectiveness of Breast Irradiation Following Lumpectomy and Axillary Disection for Node-Negative Breast CancerJNCI Journal of the National Cancer Institute, 1992
- Exclusive radical radiation therapy in breast carcinomaRadiotherapy and Oncology, 1991
- Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-upInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1989
- Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the gustave-roussy institute and the princess margaret hospitalInternational Journal of Radiation Oncology*Biology*Physics, 1985
- The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapyThe British Journal of Radiology, 1985
- Radiation therapy with or without primary limited surgery for operable breast cancer: A 20-year experience at the marseilles cancer instituteCancer, 1982
- Conservative management of operable breast cancer.Ten years experience at the Foundation CurieCancer, 1978
- Relation between time-dose and local control of operable breast cancer treated by tumorectomy and radiotherapy or by radical radiotherapy aloneCancer, 1978
- Five-Year Results in 431 Breast Cancers Treated Solely by Roentgen RaysAnnals of Surgery, 1965